Abstract
Patients with life-threatening movement disorder emergencies may be encountered in the hospital or intensive care unit. Prompt and aggressive diagnosis and management is required to prevent morbidity and mortality. Management begins in parallel while identification of etiologies and/or precipitating factors occurs: stabilizing the patient is the priority. Management can be divided into acute management (the first 24 hours), and the time that follows. In the first 24 hours, the aim is to stabilize the patient and provide symptomatic treatment. After the first 24 hours, treatment focuses on continuation of symptomatic and/or specific therapies, as well as prevention of recurrence. Phenomenology plays a critical role in the diagnosis and management of these patients, as their ability to communicate is often limited.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Poston KL, Frucht SJ. Movement disorder emergencies. J Neurol. 2008;255(Suppl 4):2–13. https://doi.org/10.1007/s00415-008-4002-9.
Varley JA, Webb AJS, Balint B, Fung VSC, Sethi KD, Tijssen MAJ, et al. The movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study. J Neurol Neurosurg Psychiatry. 2019;90(6):724–6. https://doi.org/10.1136/jnnp-2018-318584.
Termsarasab P, Thammongkolchai T, Katirji B. Emergencies in stiff-person spectrum disorders. In: Stiff-person syndrome and related disorders. Cham: Springer; 2020.
Blumin JH, Berke GS. Bilateral vocal fold paresis and multiple system atrophy. Arch Otolaryngol Head Neck Surg. 2002;128(12):1404–7. https://doi.org/10.1001/archotol.128.12.1404.
Dobbs M, Berger JR. Cervical myelopathy secondary to violent tics of Tourette's syndrome. Neurology. 2003;60(11):1862–3. https://doi.org/10.1212/01.wnl.0000064285.98285.cf.
Friedman JH, Feinberg SS, Feldman RG. A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal. JAMA. 1985;254(19):2792–5. https://doi.org/10.1001/jama.1985.03360190098033.
Granner MA, Wooten GF. Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome. Semin Neurol. 1991;11(3):228–35. https://doi.org/10.1055/s-2008-1041226.
Termsarasab P, Frucht SJ. Dystonic storm: a practical clinical and video review. J Clin Mov Disord. 2017;4:10. https://doi.org/10.1186/s40734-017-0057-z.
Fink RA. Myoglobinuria in neuroleptic malignant syndrome. Arch Intern Med. 1985;145(9):1736. https://doi.org/10.1001/archinte.1985.00360090212035.
Bertorini TE. Myoglobinuria, malignant hyperthermia, neuroleptic malignant syndrome and serotonin syndrome. Neurol Clin. 1997;15(3):649–71. https://doi.org/10.1016/s0733-8619(05)70338-8.
Faulds M, Meekings T. Temperature management in critically ill patients. Contin Educ Anaesth Crit Care Pain. 2013;13(3):75–9. https://doi.org/10.1093/bjaceaccp/mks063.
Lopez GA. Temperature Management in the Neurointensive Care Unit. Curr Treat Options Neurol. 2016;18(3):12. https://doi.org/10.1007/s11940-016-0393-6.
Vazquez-Sandoval A, Ghamande S, Surani S. Critically ill patients and gut motility: are we addressing it? World J Gastrointest Pharmacol Ther. 2017;8(3):174–9. https://doi.org/10.4292/wjgpt.v8.i3.174.
Ben-Haim S, Flatow V, Cheung T, Cho C, Tagliati M, Alterman RL. Deep brain stimulation for status dystonicus: a case series and review of the literature. Stereotact Funct Neurosurg. 2016;94(4):207–15. https://doi.org/10.1159/000446191.
Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007;164(6):870–6. https://doi.org/10.1176/ajp.2007.164.6.870.
Sarkar S, Gupta N. Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association. BJPsych Bull. 2017;41(4):211–6. https://doi.org/10.1192/pb.bp.116.053736.
Allen NM, Lin JP, Lynch T, King MD. Status dystonicus: a practice guide. Dev Med Child Neurol. 2014;56(2):105–12. https://doi.org/10.1111/dmcn.12339.
Mariotti P, Fasano A, Contarino MF, Della Marca G, Piastra M, Genovese O, et al. Management of status dystonicus: our experience and review of the literature. Mov Disord. 2007;22(7):963–8. https://doi.org/10.1002/mds.21471.
Frucht SJ. Treatment of movement disorder emergencies. Neurotherapeutics. 2014;11(1):208–12. https://doi.org/10.1007/s13311-013-0240-3.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Termsarasab, P. (2022). Practical Approach to Management of the Movement Disorders Patient in the Hospital and Intensive Care Unit. In: Frucht, S.J. (eds) Movement Disorder Emergencies. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-030-75898-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-75898-1_1
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-75897-4
Online ISBN: 978-3-030-75898-1
eBook Packages: MedicineMedicine (R0)